I just heard back from Gerald. He will be addressing the market tomorrow, saying there is lots to talk about.

I don't have permission to share his email, so I won't. He did state that today's data thoroughly impressed the biomarker specialists at the conference, and was exactly what big pharma was wanting to see.

I look forward to his words tomorrow. Please, no one ask via PM that I forward his email. It doesn't contain any privileged info. I'm sure everything he remarked on will be shared with all shareholders tomorrow. I want to keep my lines of communication open with our CEO and not jeopardize it by sharing an email I don't have permission to share.